MagPlex C Microsphere Beads
ID: 75D30124Q78391Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/530f65d173ca44db935b649138f63799/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking quotations for the supply of MagPlex C Microsphere Beads, which are critical for serological assays used to quantify antibodies for various disease targets in public health surveillance. These microspheres are uniquely compatible with the CDC's existing assays based on Luminex’s Xmap technology, and no alternative products have been identified that can replace them without compromising the integrity of past study comparisons. Interested vendors must submit their quotations by 5:00 PM EST on September 10, 2024, with delivery expected by December 31, 2024; inquiries should be directed to Gary Morgan at glm5@cdc.gov or by phone at 770-488-2639.

    Point(s) of Contact
    Gary Morgan
    (770) 488-2639
    (770) 488-2777
    glm5@cdc.gov
    Files
    Title
    Posted
    75D30124Q78391 MagPlex C Microsphere Beads.doc
    The document is a Request for Quotations (RFQ) issued by the Centers for Disease Control and Prevention (CDC), seeking quotes for MagPlex-C microsphere beads for various regions. The RFQ, numbered 75D301-24-Q-78391, communicates a solicitation to vendors, indicating that it is not an order but a request for information. It specifies that bids should be submitted via email by September 5, 2024, and stresses that deliveries must occur by December 31, 2024. The RFQ outlines the quantities required for different regions, totaling 22 individual items of 4ml microsphere beads each. The document incorporates various Federal Acquisition Regulation (FAR) clauses, detailing obligations related to payment, contractor performance evaluation, and compliance with accessibility standards. It encourages small business participation but does not initially set aside an allocation for them. The RFQ's structure adheres to common federal procurement procedures, providing detailed instructions for contractors regarding compliance, performance assessment, and payment processes.
    75D30124Q78391 MagPlex C Microsphere Beads extend RFQ Sept 9.doc
    The document is a Request for Quotations (RFQ) issued by the Centers for Disease Control and Prevention (CDC) on August 28, 2024. It seeks quotes for the supply of MagPlex-C Microsphere Beads in various regional quantities. The RFQ emphasizes that it is not an order, nor does it commit the government to payment for any preparation costs. Interested parties must submit their quotations by September 10, 2024, and provide delivery by December 31, 2024. The document outlines the necessary details, including the point of contact, Gary Morgan, along with guidelines for quote submissions, payment terms, and clauses incorporated by reference regarding contractor performance and compliance with federal regulations. Additionally, it highlights the importance of adhering to supply chain security standards and accessibility requirements under Section 508 of the Rehabilitation Act. The RFQ is aimed at ensuring compliance with contracting rules and is designed to facilitate the procurement process for necessary supplies to support CDC operations effectively.
    Lifecycle
    Title
    Type
    MagPlex C Microsphere Beads
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Diagnostic Test Development and Production for Emergency Response
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the development and production of diagnostic tests aimed at enhancing emergency response capabilities for public health threats. The procurement involves a range of tasks, including the rapid development and validation of Nucleic Acid Amplification Tests for selected pathogens, regulatory submissions for Emergency Use Authorization (EUA) or 510(k) approval, and the manufacturing of tests to meet outbreak demands. This initiative is critical for bolstering the national laboratory system's readiness and efficiency in addressing public health emergencies. Proposals are due by December 2, 2024, with a maximum contract value of $148 million and a minimum order of $10,000. Interested parties can contact Shayna Connery at xvj9@cdc.gov or (404) 498-0715 for further information.
    RISER Meet and Greet
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking qualified large businesses under NAICS 325413, In-Vitro Diagnostic Substance Manufacturing, to participate in the RISER Meet and Greet initiative aimed at enhancing public health surveillance and laboratory capacity. This opportunity is part of a phased approach to identify capable businesses that can provide diagnostic and testing services, ultimately expanding the CDC's inventory of reference pathogens and detection kits for rapid response during public health emergencies. Interested parties must respond by November 14, 2024, with their capabilities and relevant past performance, as the virtual meet-and-greet conference is scheduled for December 11, 2024. For further inquiries, interested businesses can contact Jennifer Gartzke at jgartzke@cdc.gov or call 404-498-0020.
    Serological Assays for the detection and characterization of influenza viruses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the provision of serological assays aimed at detecting and characterizing influenza viruses. This contract encompasses a 12-month base period with four additional 12-month option periods, focusing on testing immunological responses from human samples collected during vaccine effectiveness studies, randomized controlled trials, and outbreak investigations using Hemagglutination Inhibition (HAI) assays. The services are critical for understanding vaccine efficacy and managing influenza outbreaks, with the government supplying necessary standard operating procedures, proficiency panels, and controls to ensure proper assay performance. Interested parties should contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further details, as this opportunity is set aside for small businesses under the SBA guidelines.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    Qiagen LLC QIAsymphony DSP DNA Midi Kits, filter tips and supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole source firm fixed-price purchase order to Qiagen LLC for QIAsymphony DSP DNA Midi Kits, filter tips, and related supplies, essential for the Microbiology Service section of the Department of Laboratory Medicine. This procurement aims to acquire reagents and supplies necessary for the efficient extraction of nucleic acids from clinical samples, which is critical for timely detection of infectious agents and supporting ongoing clinical testing. The items will be utilized with existing QIAsymphony SP and QIAgility instruments, which are vital for the laboratory's operations and the development of novel tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 2:30 PM EST, as this is not a request for proposals.
    Pediatric Flu Vaccine – 2025-2026
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking proposals for the procurement of pediatric influenza vaccines for the 2025-2026 season under solicitation number 75D301-25-R-73215. The CDC requires one or more indefinite quantity, indefinite delivery contracts for the purchase of vaccines specifically for children aged 0 through 18 years, with a minimum order size of 100 doses and a maximum of 30 million doses, to support immunization programs under the Vaccine for Children (VFC) program. This initiative is crucial for enhancing public health by ensuring the availability of quality vaccines to reduce healthcare costs associated with preventable diseases. Proposals are due by November 12, 2024, and interested parties should direct inquiries to Matheu Wilson at zlb4@cdc.gov or David Dombeck at vwj8@cdc.gov.
    Adult Flu Vaccines 2025-2026
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is soliciting proposals for Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts to procure adult influenza vaccines for the 2025-2026 season. The procurement aims to utilize Section 317 vaccine purchase funds to provide state and local health departments with access to vaccines at favorable prices, particularly targeting populations at higher risk of under-vaccination. This initiative includes a minimum order of 100 doses and a maximum of 6 million doses, with strict compliance to FDA standards and specific delivery requirements. Proposals are due by November 12, 2024, and interested parties should direct inquiries to Matheu Wilson at zlb4@cdc.gov or David Dombeck at vwj8@cdc.gov. The contract period will extend from the date of award through February 28, 2026.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.
    Sources Sought Notice for a Cost-Per-Test (CPT) Agreement to include reagents, instrument/equipment, consumables, controls, and any necessary services to conduct Flow Cytometry Testing at BAMC
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement to provide flow cytometry testing services at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of FDA-approved reagents, instruments, consumables, controls, and necessary services, with a focus on maintaining a 98% operational uptime during business hours and ensuring compliance with regulatory standards such as CLIA and CAP. This initiative is critical for the Department of Pathology and Area Laboratory Services at BAMC, as it supports essential diagnostic testing and patient care. Interested vendors must submit their responses, including company information and capability statements, by 4:00 PM CST on October 30, 2024, to the designated contacts, Medina L. Woodson and Salameya Paulouskaya, via the provided email addresses.
    Procurement of storage and stability services to maintain BARDA’s supply of Live Attenuated Influenza Virus Master and Working Seed Lots
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS), specifically the Biomedical Advanced Research and Development Authority (BARDA), is seeking to procure storage and stability services for maintaining its supply of Live Attenuated Influenza Virus Master and Working Seed Lots. The procurement aims to ensure that these seed lots remain within specification for use in clinical trials or commercial drug production, which is critical for pandemic preparedness. The contract will be awarded on a sole source basis to MedImmune, LLC, which has been performing these services under a previous indefinite-delivery, indefinite-quantity contract since 2016. Interested parties may submit capability statements or quotations for consideration, and inquiries can be directed to Deitra Williams at deitra.williams@hhs.gov or Corneilus Stephens at corneilus.stephens@hhs.gov.